TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -464.71% and +0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?